ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q957. A total of 5 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $559,000 | +46.0% | 10,900 | +78.7% | 0.00% | +100.0% |
| Q1 2016 | $383,000 | +40.3% | 6,100 | +110.3% | 0.00% | +100.0% |
| Q4 2015 | $273,000 | -67.3% | 2,900 | -72.1% | 0.00% | -66.7% |
| Q3 2015 | $836,000 | -50.2% | 10,400 | -25.7% | 0.00% | -62.5% |
| Q2 2015 | $1,678,000 | +179.7% | 14,000 | +47.4% | 0.01% | +166.7% |
| Q2 2014 | $600,000 | -70.2% | 9,500 | -68.3% | 0.00% | -66.7% |
| Q1 2014 | $2,014,000 | +606.7% | 30,000 | +226.1% | 0.01% | +800.0% |
| Q2 2013 | $285,000 | – | 9,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 84,300 | $15,917,000 | 0.02% |
| SIMPLEX TRADING, LLC | 33,600 | $5,703,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 36,000 | $6,797,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |